Increasing psychopharmacology clinical trial success rates with digital measures and biomarkers

Summary

The article discusses the challenge of heterogeneity and comorbidity in psychiatric disorders, affecting drug development and diagnosis. It connects to 'epidemiology' by highlighting these issues within public health, diagnosis, and treatment reliability. Tags reflect relevant themes, including comorbidity, mental disorders, and novel frameworks in psychiatric diagnosis, mentioning key figures and conditions.